← Leaderboards
Michael K Gould
University Of Florida
$4,461,814
Attributed
$9,659,758
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,996,824 · 3
AHRQ$3,662,934 · 1
By mechanism
R01$5,996,824 · 3
K12$3,662,934 · 1
Top collaborators
- Dejana K Braithwaite10 shared
- Gerard A Silvestri7 shared
- Michael K Ong6 shared
- Yi Guo3 shared
- Jihyoun Jeon2 shared
Most similar at University Of Florida
Same institution · by research overlap
- Yi Guo$3,756,653
- Dejana K Braithwaite$4,149,456
- Gerard A Silvestri$1,890,265
- Elizabeth A Shenkman$13,048,879
- Hui Shao$4,879,138
Others in their field
Top investigators on “Funding”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,479,940,681
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$358,470,093
Research focus
FundingDecision MakingMalignant Neoplasm Of LungPoliciesModels And SimulationPatient PopulationLung Cancer ScreeningClinical PracticeLungLinkCancer EtiologyMemberPatient OrientedDiagnosisCessation Of LifeEthnic OriginGeographyCompare EffectivenessComorbidityElectronic Health RecordCancer PatientInfrastructureProspective CohortPublic Health
Grant awards (21)
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$637,797
R01 · FY2025 · CA
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2)$543,139
R01 · FY2025 · CA
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$608,786
R01 · FY2024 · CA
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2)$497,819
R01 · FY2024 · CA
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$65,002
R01 · FY2024 · CA
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2)$556,496
R01 · FY2023 · CA
Diversity Supplement: Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$55,355
R01 · FY2023 · CA
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$626,652
R01 · FY2022 · CA
Stakeholder-Partnered Implementation Research and Innovation Translation (SPIRIT) program$611,758
K12 · FY2022 · HS
Stakeholder-Partnered Implementation Research and Innovation Translation (SPIRIT) program$743,637
K12 · FY2021 · HS
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$637,512
R01 · FY2021 · CA
PA-20-072 Stakeholder-Partnered Implementation Research and Innovation Translation (SPIRIT) Program: Vulnerable Populations Cared for by Learning Health Systems During the COVID-19 Pandemic$81,000
K12 · FY2021 · HS
Stakeholder-Partnered Implementation Research and Innovation Translation (SPIRIT) program$747,834
K12 · FY2020 · HS
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$689,368
R01 · FY2020 · CA
Stakeholder-Partnered Implementation Research and Innovation Translation (SPIRIT) program$726,656
K12 · FY2019 · HS
Stakeholder-Partnered Implementation Research and Innovation Translation (SPIRIT) program$752,049
K12 · FY2018 · HS
Evaluation of Computerized Decision Support for Managing Lung Nodules$179,110
R01 · FY2011 · CA · contact PI
Evaluation of Computerized Decision Support for Managing Lung Nodules$99,848
R01 · FY2011 · CA · contact PI
Evaluation of Computerized Decision Support for Managing Lung Nodules$301,168
R01 · FY2010 · CA · contact PI
Evaluation of Computerized Decision Support for Managing Lung Nodules$281,023
R01 · FY2009 · CA · contact PI
Computerized Decision Support for Managing Lung Nodules$217,749
R01 · FY2006 · CA · contact PI